期刊文献+

顺式阿曲库铵应用于小儿的药效动力学研究 被引量:15

Pharmacodynamics of cisatracurium in children
下载PDF
导出
摘要 目的探讨顺式阿曲库铵应用于小儿的肌松效应。方法择期手术患儿180例,ASAⅠ或Ⅱ级,按三个年龄段分为婴儿组(Ⅰ组)、幼儿组(Ⅱ组)和儿童组(Ⅲ组),每组再分别按2ED95或3ED95的剂量分组,共6组(Ⅰ2、Ⅰ3、Ⅱ2、Ⅱ3、Ⅲ2、Ⅲ3),每组30例。连续监测ECG、SpO2、PETCO2、HR及拇内收肌诱发肌颤搐反应的变化。于5s内单次静脉注入顺式阿曲库铵0.10mg/kg或0.15mg/kg,待四个成串刺激(TOF)的T1为0时行气管插管,并对插管条件进行评级。观察阻滞起效时间、TOF无反应期、阻滞维持时间、肌松恢复指数及体内作用时间。结果Ⅰ3、Ⅱ3、Ⅲ3组起效时间显著短于Ⅰ2、Ⅱ2、Ⅲ2组(P<0.05),且Ⅰ2和Ⅰ3较其他组起效时间明显缩短(P<0.05)。Ⅰ3、Ⅱ3、Ⅲ3组气管插管条件为优的比率明显高于Ⅰ2、Ⅱ2、Ⅲ2组(P<0.05)。Ⅰ3、Ⅱ3、Ⅲ3组的TOF无反应期、阻滞维持时间、体内作用时间明显长于Ⅰ2、Ⅱ2、Ⅲ2组(P<0.05);Ⅰ2组TOF无反应期、阻滞维持时间、体内作用时间明显长于Ⅱ2、Ⅲ2组(P<0.05);Ⅰ3组TOF无反应期、阻滞维持时间、体内作用时间明显长于Ⅱ3、Ⅲ3组(P<0.05)。但是肌松恢复指数在各组差异无统计学意义。结论顺式阿曲库铵3ED95诱导剂量应用于婴、幼儿和儿童均是安全有效的,其起效和插管条件均优于2ED95。且婴儿较年长儿更为敏感。肌松恢复时间与剂量、年龄无关。 Objective To study the pharmacodynamic features of cisatracurium in children. Methods One hundred and eighty patients were randomized to group Ⅰ , group Ⅱ and group Ⅲ. Each group was subdivided according to the dose of cisatracurium, 0. 10 mg/kg (2ED95) or 0.15 mg/kg (3ED95) into group Ⅰ2, Ⅰ3, Ⅱ2,Ⅱ3, Ⅲ2, Ⅲ3 (n=30). ECG, SpO2,PETCO2, HR and neuromuscular blockade were monitored. Intubation conditions were assessed when T1 was zero after cisatracurium administration using a 4-part scale. The onset time, TOF no reaction period, duration of action, recovery index, and hemodynamic responses were recorded. Results The onset times of group Ⅰ 3, Ⅱs and Ⅲ3 were 102.5 s, 178.8 s and 185.5 s, which were significantly shorter than those of groupⅠ 2, Ⅱ2 and Ⅲ2(118.8 s, 246.8 s and 250.2 s) (P〈0.05). The percentages of patients with excellent intubation condition in group Ⅰ3, Ⅱ3 and Ⅲ3 were 90%, 90%, and 80%, which were markedly higher than those in group Ⅰ2 , Ⅱ 2 and Ⅲ2 (70%, 60%, 60%). TOF no reaction period and duration of action were longer in group Ⅰ3, Ⅱ3 and Ⅲ3 than those in group Ⅰ2, Ⅱ2 and Ⅲ2 There was no any significant difference in recovery index among the six groups. Conclusion Cisatracurium 0. 15 mg/kg produces quicker onset time and acceptable intubation conditions in the great majority of infants, baby and children than 0. 10 mg/kg. Infants are more sensitive to cisatracurium with faster onset time and longer duration of action than children, but recovery index is independent on the dosage and age.
出处 《临床麻醉学杂志》 CAS CSCD 2007年第10期821-823,共3页 Journal of Clinical Anesthesiology
关键词 顺式阿曲库胺 药效学 小儿 Cisatracurium Pharmacodynamics Children
  • 相关文献

参考文献10

  • 1Melloni C,Devivo P,Launo C,et al.Cisatracurium versus vecuronium:a comparative,double blind,randomized,multicenter study in adult patients under propofol/fentanyl/N2Oanesthesia.Minerva Anestesiol,2006,72:299-308. 被引量:1
  • 2Doenicke AW,Czeslick E,Moss J,et al.Onset time,endotracheal intubating conditions,and plasma histamine after cisatracurium and vecuronium administration.Anesth Analg,1998,87:434-438. 被引量:1
  • 3Kirov K,Motamed C,Decailliot F,et al.Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.Acta Anaesthesiol Scand,2004,48:577-581. 被引量:1
  • 4刘威,闻大翔,杭燕南,孙大金.四种中时效非去极化肌松药组胺释放作用的研究[J].上海第二医科大学学报,2003,23(5):445-448. 被引量:31
  • 5闻大翔,陈锡明,杭燕南,孙大金.顺式阿曲库铵的组胺释放作用及其对血液动力学的影响[J].中华麻醉学杂志,2001,21(2):69-72. 被引量:69
  • 6Soukup J,Czeslick E,Bunk S,et al.Cisatracurium in patients with compromised kidney function.Pharmacodynamic and intubation conditions under isoflurane-nitrous oxide anesthesia.Anaesthesist,1998,47:669-676. 被引量:1
  • 7闻大翔,陈锡明,杭燕南,孙大金.顺式阿曲库铵在肾移植麻醉中的药效学研究[J].上海第二医科大学学报,2002,22(6):517-519. 被引量:24
  • 8Taivainen T,Meakin GH,Meretoja OA,et al.The safety and efficacy of cisatracurium 0.15 mg · kg-1 during nitrous oxideopioid anaesthesia in infants and children.Anaesthesia,2000,55:1047-1051. 被引量:1
  • 9de Ruiter J,Crawford MW.Dose-response relationship and infusion requirement of cisatracurium besylate in infants and children during nitrous oxide-narcotic anesthesia.Anesthesiology,2001,94:790-792. 被引量:1
  • 10Kenaan CA,Estacio RL,Bikhazi GB.Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia.J Clin Anesth,2000,12:173-176. 被引量:1

二级参考文献23

  • 1郑武飞.实用临床免疫学技术[M].北京:人民卫生出版社,1987.186. 被引量:4
  • 2Rosow CE, Basta SJ, Savarese JJ, et al. Correlation of cardiovascular effects with increases in plasma histamineC J]. Anesthesiology,1980, 53 : S270. 被引量:1
  • 3Verburg KM, Bowsher RR, Henry DP. A new radioenzymatic assay for histamine using purified histamine N-methyltransferase [ J ]. Life Scienses, 1983, 32:2855 -2867. 被引量:1
  • 4Moss J. Muscle relaxants and histamine release[ J]. Acta Anaesthesiol Scand, 1995, 106 (Suppl) : 7 - 12. 被引量:1
  • 5Belmont MR, Lien CA, Quassy S, et aL The clinic neuromuscular pharmacology of 51 W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia [ J ]. Anesthesiology, 1995, 82:1139 -1145. 被引量:1
  • 6Litdejohn IH, Abhay K, El Sayed PJ. Intubating conditions following 1R cis -1' R cis atracurium (51W89) [ J ]. Anaesthesia, 1995,50:499 - 502. 被引量:1
  • 7Boyd AH, Eastwood, NB, Parker CJR, et al. Pharmaco - dynamics of the 1R cis - 1' R cis isomer of atracurium ( 51 W89 ) in health and chronic renal failure[J]. Br J Anaesth, 1995, 74:400 -404. 被引量:1
  • 8Basta S J, Savarese JJ, Ali HH, et al. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine [ J]. Br J Anaesth, 1983, 55:105S-106S. 被引量:1
  • 9Watkins J. Histamine release by atracurium [ J ]. Br J Anaesth,1986,58 : 19S - 22S. 被引量:1
  • 10Scott RPF, Savarese JJ, Basta SJ, et al. Atmcurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response[ J]. Br J Anaesth, 1985, 57:550 - 553. 被引量:1

共引文献100

同被引文献146

引证文献15

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部